A novel TBX5 loss-of-function mutation associated with sporadic dilated cardiomyopathy

Wei Zhou1, Lan Zhao2, Jin-Qi Jiang3

  • 1Department of Emergency Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, P.R. China.

Insights

Genetic mutations in the TBX5 gene are linked to dilated cardiomyopathy (DCM), a common heart condition. A novel TBX5 mutation, p.A143T, was found to decrease gene activity, increasing susceptibility to sporadic DCM.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is the most common primary cardiomyopathy and a leading cause of heart failure and transplantation.
  • Genetic factors are implicated in DCM, with mutations identified in over 50 genes, yet the genetic basis remains unknown in many cases.
  • TBX5, a T-box transcription factor, is crucial for cardiac development.

Purpose of the Study:

  • To investigate the role of the TBX5 gene in sporadic dilated cardiomyopathy.
  • To identify novel mutations in TBX5 associated with DCM and elucidate their functional consequences.

Main Methods:

  • Sequencing of the TBX5 gene (coding exons and flanking intron-exon boundaries) in 146 unrelated patients with sporadic DCM.
  • Functional analysis of identified TBX5 mutations using a dual-luciferase reporter assay.
  • Comparison of mutant TBX5 activity with wild-type TBX5 and its interaction with GATA4.

Main Results:

  • A novel heterozygous TBX5 mutation, p.A143T, was identified in a patient with sporadic DCM and was absent in 400 control chromosomes.
  • The p.A143T mutation, affecting a conserved amino acid, significantly reduced TBX5 transcriptional activity on the atrial natriuretic factor (ANF) gene promoter.
  • This mutation abolished the synergistic activation of the ANF promoter by TBX5 and GATA4.

Conclusions:

  • This study reports the first association of a TBX5 loss-of-function mutation with increased susceptibility to sporadic DCM.
  • The findings provide new insights into the molecular mechanisms underlying DCM pathogenesis.
  • The results suggest potential implications for prenatal prophylaxis and personalized treatment strategies for DCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
767
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
801
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
884
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
848
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
695
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.2K